181
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Condition(s): Neoplasms Last Updated: April 12, 2013Recruiting
4028 Clinical Trials for: MTD, Page 10 of 202
Hide Studies Not Seeking New Volunteers
182
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
Condition(s): Hematologic Malignancy; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Hodgkin's Disease Last Updated: January 10, 2013Active, not recruiting
183
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
Condition(s): Advanced Solid Tumours; Cancer; Lung Cancer, Non-Small Cell Last Updated: May 31, 2012Completed
184
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Condition(s): B-cell Malignancies Last Updated: April 12, 2013Active, not recruiting
185
Cabazitaxel - PF Induction Chemotherapy
Condition(s): Squamous Cell Carcinoma of the Head and Neck Last Updated: November 1, 2011Recruiting
186
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
Condition(s): Tumors; Lymphoma; Multiple Myeloma Last Updated: July 26, 2011Completed
187
Lenalidomide and Paclitaxel in Advanced Solid Tumors
Condition(s): Advanced Solid Tumors Last Updated: September 12, 2011Active, not recruiting
188
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
Condition(s): Hodgkin's Lymphoma Last Updated: May 8, 2008Recruiting
189
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Condition(s): Gastrointestinal Neoplasms Last Updated: September 22, 2012Recruiting
190
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Condition(s): Advanced and Selected Solid Tumors Last Updated: November 26, 2012Recruiting
191
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies
Condition(s): Hematologic Malignancies Last Updated: December 6, 2012Active, not recruiting
192
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Cancer Last Updated: October 18, 2012Active, not recruiting
193
A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.
Condition(s): Neoplasms Last Updated: July 15, 2009Completed
194
Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients
Condition(s): Breast Cancer; Hematologic Neoplasms Last Updated: May 10, 2013Completed
195
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: January 7, 2013Completed
196
CNDO-109-AANK for AML in First Complete Remission (CR1)
Condition(s): Acute Myeloid Leukemia Last Updated: March 26, 2013Recruiting
197
A Study of MK2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (2206-015)
Condition(s): Advanced Solid Tumors; Breast Cancer Last Updated: March 6, 2012Completed
198
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
Condition(s): Breast Cancer; Colon Cancer; Ovarian Cancer; Endometrium Cancer Last Updated: April 9, 2013Completed
199
A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride
Condition(s): Constipation Last Updated: May 28, 2008Completed
200
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
Condition(s): Neoplasms Last Updated: April 17, 2013Completed
